Tokyo, Japan

Yugo Uchida


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Medicinal Chemistry: The Contributions of Yugo Uchida

Introduction

Yugo Uchida, an accomplished inventor based in Tokyo, Japan, has made significant strides in the field of medicinal chemistry. With a focus on developing effective treatments for cancer patients, his work aims to enhance the quality of life for those undergoing challenging therapies.

Latest Patents

Yugo Uchida holds a notable patent titled "Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent." This invention addresses the side effects experienced by cancer patients treated with oxaliplatin, an anti-malignant tumor agent. The patent describes a medicament that combines thrombomodulin, administered intravenously in a specific dosage during treatment cycles, to alleviate the symptoms associated with peripheral neuropathy.

Career Highlights

Throughout his career, Yugo Uchida has worked with Asahi Kasei Pharma Corporation, where he plays a crucial role in research and development. His commitment to finding innovative solutions in oncology showcases his dedication to the medical field and the well-being of patients.

Collaborations

Uchida collaborates with esteemed colleagues, such as Takumi Sakai and Genichi Kusakawa, fostering a conducive environment for groundbreaking research. Their combined expertise enhances the work being done at Asahi Kasei Pharma Corporation, pushing the boundaries of what is possible in treating cancer-related ailments.

Conclusion

In summary, Yugo Uchida's contributions to medicinal chemistry and his patent addressing peripheral neuropathy exemplify the vital role of inventors in advancing healthcare. His collaborative efforts within Asahi Kasei Pharma Corporation highlight the importance of teamwork in achieving significant innovations in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…